Glaxo Type 2 Diabetes Treatment Tanzeum Available In US Pharmacies

Tue, 29th Jul 2014 13:30

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that its once-weekly type 2 diabetes treatment Tanzeum is now available in US pharmacies.

Glaxo said that it is committed to taking a responsible approach to pricing, and that Tanzeum has been priced in line with this commitment.

Tanzeum was approved by the US Food and Drug Administration April 15. It is not recommended as a first line therapy for patients whose diabetes is inadequately controlled by diet and exercise.

Shares in GlaxoSmithKline were trading up 0.9% at 1,426.50 pence Tuesday afternoon.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Related Shares

More News

11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but th...

11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its disc...

11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidi...

Latest Share Chat